Haejung Cha

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
299 Background: We have previously reported outcome of concurrent chemoradiotherapy (CCRT) in advanced hepatocellular carcinoma (HCC) with median survival 13.1 months. We further analyzed patterns of failure as well as related clinical factors. METHODS Retrospective cohort analysis was done for 161 HCC patients given CCRT between May 2000 and August 2009.(More)
  • 1